Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

44.12 -0.34 (-0.76%)
Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
Pfizer In-Licenses Voyager Therapeutics' AAV Capsid For Rare Neurologic Disease Target
 
Via Benzinga
Pfizer Touts Positive Data From Prostate Cancer Combo Therapy Trial
 
Via Benzinga
7 Most Undervalued Stocks to Buy Now
The market downturn has lowered the prices of some of the best stocks available to investors, creating great, undervalued stocks to buy now. 
Via InvestorPlace
Myovant Sciences Rockets After Rejecting Lowball Sumitovant Biopharma Takeover Bid
Myovant shares rocketed to a year-high after turning down Sumitovant's offer. 
Via Investor's Business Daily
Top Five Weekend Stock Stories - Sunday, Oct. 2nd
Catch up on the weekend's top five stories with this must read list. 
Via Talk Markets
7 S&P 500 Stocks to Sell Before They Die
Investors should unload these S&P 500 stocks to sell and recognize that their fortunes have taken a dramatic turn for the worse. 
Via InvestorPlace
What Are Whales Doing With Pfizer
A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 11 strange trades. 
Via Benzinga
Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries
 
Via Benzinga
4 Blue-Chip Stocks to Sell in October
Blue-chip stocks to sell as they seem to be trading at stretched valuations considering the economic outlook. These stocks are worth accumulating after a correction of 10% to 20%. 
Via InvestorPlace
Biohaven's ALS Drug Fails To Meet Study Endpoint, Second Therapy To Fail Trials In Recent Months
Biohaven Pharmaceutical Holding Company Ltd (NASDAQ: BHVN) announced results from a focused analysis of verdiperstat in the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis (ALS).  
Via Benzinga
Merck Inks Supply Deal With Sinopharm To Commercialize COVID-19 Pills In China
Merck & Co Inc (NYSE: MRK) signed a cooperation framework agreement in China for its COVID-19 antiviral pills, which were co-developed by Ridgeback Therapeutics.  
Via Benzinga
CDC and FDA Misinformation – Retroactive Editing, Erroneous Spontaneous Abortion Rate Calculation, Obfuscation by NEJM
Breaking: Cause of Mortality and Injury to Infants and Fetuses caused by the Pfizer Injections Via Tainted Breast Milk and Compromised Placenta Membranes were Quashed by the US Health Agencies – an... 
Via Newsworthy
Exposures COVID-19 Product Safety
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
 
Via Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over. 
Via InvestorPlace
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
Bloomberg 
Via Benzinga
Pfizer/BioNTech Seek FDA Emergency Nod For Updated COVID-19 Shot For Kids Under 11 Years
 
Via Benzinga
Pfizer CEO Contracts COVID-19 Infection For Second Time
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla said he had tested positive for COVID-19. 
Via Benzinga
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges
Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the... 
Via Benzinga
Switzerland To Dispose 10M Expired COVID-19 Vaccine Doses From Moderna
 
Via Benzinga
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
 
Via Benzinga
The Worst Thing That Can Happen to the Human Species, is Happening – Dr. Naomi Wolf is Available for Interview
In this powerful summary of the Covid years - target – truth teller - concerned citizen Dr. Naomi Wolf reports on the newly discovered harms to reproductive health caused by Covid vaccines and the... 
Via Newsworthy
Topics Lawsuit
Exposures COVID-19 Financial Legal
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak
In the U.S., Novavax is going after the 10% of unvaccinated adults. 
Via Investor's Business Daily
The 'Transformative' Eli Lilly Drug That Could Top $25 Billion In Annual Sales
The drug already has one FDA approval as Lilly angles for a second. 
Via Investor's Business Daily
Why Is Novavax (NVAX) Stock Falling Today?
Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again. 
Via InvestorPlace
This Is What Whales Are Betting On Pfizer
A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 18 strange trades. 
Via Benzinga
5 Dividend Growth Stocks That Have Totally Collapsed
Today, I want to tell you about 5 dividend growth stocks that are down more than 20% from their recent highs. 
Via Talk Markets
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology. 
Via InvestorPlace
Analysts Put Alnylam On Upside Catalyst Watch Ahead Of Upcoming Data From Lead Program
 
Via Benzinga
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
88 89 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.